Chris Heery MD

CMO Precision Biosciences

Dr. Chris Heery is Chief Medical Officer, responsible for the overall clinical development strategy and execution across the portfolio of potential therapeutics at Precision BioSciences. Before joining Precision, Chris served as Chief Medical Officer of Bavarian Nordic where he oversaw clinical development programs for the company’s immune-oncology and infectious diseases portfolios. Prior to this, he was Head of the Clinical Trials Group of the Laboratory of Tumor Immunology and Biology at the National Cancer Institute (NCI). During his time at NCI, he joined the NCI Medical Oncology Branch as a Medical Oncology Fellow in 2009 and held an Adjunct Appointment in the Genitourinary Malignancies Branch. At NCI, Chris was also part of the larger effort of the Laboratory of Tumor Immunology and Biology to create new immunotherapies for the treatment of cancer. He is board certified in medical oncology and internal medicine with primary expertise in the translational and clinical development of immunotherapies. Chris completed his internal medicine residency at the University of Illinois at Chicago after receiving his M.D. from East Carolina University Brody School of Medicine and a B.A. in English Literature from Duke University. Chris is also a member of the Board of Directors for the Chordoma Foundation and the Medical Advisory Board of Fight Colorectal Cancer. When Chris is not working, he enjoys spending time with his family and watching Duke basketball.